Vanguard Group Inc Myriad Genetics Inc Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 10,591,043 shares of MYGN stock, worth $155 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,591,043

Previous 10,311,664 2.71%

Holding current value

$155 Million

Previous $282 Million 48.55%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$13.17 - $27.03 $3.68 Million - $7.55 Million	279,379 Added 2.71%	10,591,043 $145 Million
Q3 2024 Nov 13, 2024	BUY	$23.97 - $28.6 $5.92 Million - $7.06 Million	246,993 Added 2.45%	10,311,664 $282 Million
Q2 2024 Aug 13, 2024	BUY	$17.98 - $25.47 $520,754 - $737,687	28,963 Added 0.29%	10,064,671 $246 Million
Q1 2024 May 10, 2024	BUY	$17.59 - $23.59 $1.43 Million - $1.92 Million	81,475 Added 0.82%	10,035,708 $214 Million
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $11 Million - $16.8 Million	789,496 Added 8.61%	9,954,233 $191 Million
Q3 2023 Nov 14, 2023	BUY	$15.99 - $23.22 $198,116 - $287,695	12,390 Added 0.14%	9,164,737 $147 Million
Q2 2023 Aug 14, 2023	SELL	$17.56 - $23.76 $2.56 Million - $3.47 Million	-146,067 Reduced 1.57%	9,152,347 $212 Million
Q1 2023 May 15, 2023	SELL	$15.26 - $23.75 $203,675 - $316,991	-13,347 Reduced 0.14%	9,298,414 $216 Million
Q4 2022 Feb 10, 2023	BUY	$14.51 - $20.99 $2.66 Million - $3.85 Million	183,377 Added 2.01%	9,311,761 $135 Million
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $2.22 Million - $3.39 Million	121,704 Added 1.35%	9,128,384 $174 Million
Q2 2022 Aug 12, 2022	BUY	$16.45 - $25.88 $494,931 - $778,651	30,087 Added 0.34%	9,006,680 $164 Million
Q1 2022 May 13, 2022	SELL	$22.67 - $28.01 $3.92 Million - $4.84 Million	-172,928 Reduced 1.89%	8,976,593 $226 Million
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $2.81 Million - $3.8 Million	116,324 Added 1.29%	9,149,521 $253 Million
Q3 2021 Nov 12, 2021	BUY	$29.97 - $36.66 $2.47 Million - $3.02 Million	82,377 Added 0.92%	9,033,197 $292 Million
Q2 2021 Aug 13, 2021	BUY	$25.39 - $32.61 $227 Million - $292 Million	8,950,820 New	8,950,820 $274 Million

Others Institutions Holding MYGN

# of Institutions

236

Shares Held

89.2M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.18B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Myriad Genetics Inc Transaction History